We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

47 hedge funds and large institutions have $4.45M invested in NantHealth, Inc in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

9% more funds holding

Funds holding: 4347 (+4)

30% less capital invested

Capital invested by funds: $6.36M → $4.45M (-$1.91M)

58% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 19

Holders
47
Holders Change
+4
Holders Change %
+9.3%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
8
Reduced
19
Closed
4
Calls
$20K
Puts
Net Calls
+$20K
Net Calls Change
+$8K

NH Hedge Fund Activity: Q1 2022 in Review

47 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q1 2022, worth a combined $4.45M — down 30% from $6.36M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new NH positions and 4 closed out — a net gain of 4 holders — while 8 added to existing stakes and 19 trimmed.

The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $750K. The largest seller was Vanguard Group, cutting an estimated $570K.

  • 47 institutional investors held NantHealth, Inc (NH) as of Q1 2022, up from 43 in Q4 2021.
  • Funds reported $4.45M of NantHealth, Inc stock for Q1 2022, down 30% quarter-over-quarter.
  • 8 funds opened new NantHealth, Inc positions in Q1 2022 and 4 closed out, a net change of +4 holders.
  • The largest NantHealth, Inc buyer in Q1 2022 was Highbridge Capital Management, an estimated $750K added.
  • The largest NantHealth, Inc seller in Q1 2022 was Vanguard Group, an estimated $570K sold.

Based on aggregated 13F filings for Q1 2022.